SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation

doi:10.4252/wjsc.v13.i10.1417

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7862)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

458

WORD

HTML

5082

Figures (1-9)

253

Tables (1-2)

274

Sum=6130

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

309

Download

620

Sum=929

Publishing Process of This Article

Item

Count

Browse

319

Download

484

Sum=803

Oct 26, 2021 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Oct 26, 2021; 13(10): 1417-1445
Published online Oct 26, 2021. doi: 10.4252/wjsc.v13.i10.1417

Table 2 SOX gene activity in glioblastoma and correlation with the clinical outcome of glioblastoma patients

Ref.	Gene	Activity	Clinical outcome
[94]	SOX1	Oncogenic	Poor
[98-101]	SOX2	Oncogenic	Poor
[104,105]	SOX3	Possible oncogenic	No correlation /poor
[129-131]	SOX4	Oncogenic in glioma-initiating cells; tumor suppressor in GBM	Poor/good
[115,125]	SOX5	Tumor suppressor	Poor
[116,125]	SOX6	Tumor suppressor	Poor
[117,127]	SOX7	Tumor suppressor; glioma angiogenesis	Poor
[106-108]	SOX9	Oncogenic	Poor
[110,111]	SOX10	Possible oncogenic	Poor
[119]	SOX11	Tumor suppressor	Good

Glioblastoma: GBM.

Citation: Stevanovic M, Kovacevic-Grujicic N, Mojsin M, Milivojevic M, Drakulic D. SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation. World J Stem Cells 2021; 13(10): 1417-1445
URL: https://www.wjgnet.com/1948-0210/full/v13/i10/1417.htm
DOI: https://dx.doi.org/10.4252/wjsc.v13.i10.1417